Related Experiment Video
Updated: May 9, 2026
14:10
A High Content Imaging Assay for Identification of Botulinum Neurotoxin Inhibitors
Published on: November 14, 2014
Botulinum toxin A affects early capsule formation around silicone implants in a rat model
Young Seok Kim1, Jong Won Hong, Jung Ho Yoon
1From the Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Yonsei University College of Medicine, Seoul, Korea.
Annals of Plastic Surgery
|July 16, 2013
Summary
Botulinum toxin A (BoTA) may reduce peri-implant capsule formation, a common complication of cosmetic surgery. This study found BoTA decreased capsule thickness, inflammation, and fibrosis in rats, suggesting a potential preventative treatment.
Area of Science:
- Plastic Surgery
- Biomaterials Science
- Wound Healing Research
Background:
- Capsular contracture is a frequent complication following cosmetic implants like those used in mammoplasty and rhinoplasty.
- Current prevention and treatment methods for capsular contracture are limited.
- Botulinum toxin A (BoTA) has shown efficacy in treating keloid scars, which share histological similarities with peri-implant capsules.
Purpose of the Study:
- To investigate the potential of botulinum toxin A (BoTA) in reducing peri-implant capsule formation.
- To test the hypothesis that BoTA can mitigate the development of scar tissue around implants.
Main Methods:
- 24 male Sprague-Dawley rats were used, divided into experimental (BoTA injected) and control (saline injected) groups.
- Subpanniculus pockets were created, received injections, and received silicone implants.
- Capsules were analyzed after 6 weeks using histology, immunohistochemistry, scanning electron microscopy, and real-time PCR.
Main Results:
- The BoTA group showed significantly reduced capsular thickness, inflammatory cell count, vascularity, and TGF-β1 expression (P < 0.01).
- Collagen patterns were looser and better organized in the BoTA group.
- A significantly smaller fibrosis index was observed in the BoTA group (P < 0.05).
Conclusions:
- Botulinum toxin A (BoTA) demonstrates potential as an alternative therapeutic approach to reduce peri-implant capsule formation.
- BoTA may offer a novel strategy for preventing capsular contracture after implant surgeries.
- Further research is warranted to elucidate the precise mechanisms of BoTA's action in this context.
